NSE:AUROPHARMA Buy initiate for 30 Oct 2018 using 30 min chart based on Fibonacci levels, check below buy level Buy Above : 779.05 Stop Loss : 784.2 Target : 773.35
Forming Ascending triangle pattern. Buy above 780 T1 : 809 T2 : 880 Sl: 732
We are witnessing a Triangle formation on a daily chart in NSE:AUROPHARMA . We are waiting for a Triangle Breakout on either side. Downward breakout can lead the stock to 665-675 levels whereas an Upward breakout can lead to the stock to reach around 840-850 .
Wait for PRZ and Terminal Price Bar
Current resistance 790, current support 766,,,, Reco ,, Sale - If close below 760 , Buy If close above 805
A long trade can be initiated around 675 levels, if Aurobindo Pharma sustains above it's resistance zone above 650, with targets close to 800 and a stop loss around 615. The Risk to reward is high, with the trade having high probabilities of success, if 675 is tested and our entry price is hit.
enter above 635 with above average volume stoploss 8-10% i.e..570-580 upside open...trail stoploss
I think we get to 1000 first, and then consolidate there. Here it has the option to bust up much higher to ~5000 over the next few years
Fallen from grace in Dec.2015. Once a darling of traders and investors. 3 years of correction seems coming to a close. Now Pharma industry is showing signs of sustained recovery. Price of Auro is heading towards 200 DMA. Price made two supports. Now 50 DMA is crossing 100 DMA which instills confidence. Real test will come at 200 DMA.
Auropharma is a good fundamental company and is in watchlist because Rakesh Jhunjhunwala is invested in it. Its having pressure due to its exposure to the US market. Most of the brokerage houses are maintaining the target as 850. FNO Analysis - The FNO analysis suggests huge put volume rise on 590 PE. It has a huge support at 520 and 530 levels and resistance...
Aurobindo Pharma : Breaking Down from important support level
FOR EDUCATIONAL PURPOSES. Price heading towards a decent Demand Zone. Can long with 12 Rs SL.
RSI at a monthly and weekly overbought truncation achieved at the current bottom implying strong signs of a trend reversal. Short term Targets:(rounded off) 724 800 Longer term: 900
BUY AUROPHARMA ABOVE 616 FOR SHORT TERM TARGET 660
Why should investors and traders refer to 200 DMA for taking correct trading and investing decisions? This stock study gives us insight which we can use in other cases also. Price went above this significant MA and bulls became active. It was darling to stock investors then. And below this MA bears became active. Now trend is confirmed bearish.